Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Christopher James Gibson, M.D.

Co-Author

This page shows the publications co-authored by Christopher Gibson and Peter Miller.
Connection Strength

1.647
  1. Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state. Nat Commun. 2022 06 30; 13(1):3778.
    View in: PubMed
    Score: 0.246
  2. Association of clonal hematopoiesis with chronic obstructive pulmonary disease. Blood. 2022 01 20; 139(3):357-368.
    View in: PubMed
    Score: 0.238
  3. Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy. Blood Adv. 2021 08 10; 5(15):2982-2986.
    View in: PubMed
    Score: 0.231
  4. A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade. Haematologica. 2021 02 01; 106(2):651-654.
    View in: PubMed
    Score: 0.223
  5. Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis. Blood. 2020 12 24; 136(26):3051-3055.
    View in: PubMed
    Score: 0.221
  6. Fitness Landscape of Clonal Hematopoiesis Under Selective Pressure of Immune Checkpoint Blockade. JCO Precis Oncol. 2020; 4.
    View in: PubMed
    Score: 0.217
  7. Identification of germline variants in adults with hemophagocytic lymphohistiocytosis. Blood Adv. 2020 03 10; 4(5):925-929.
    View in: PubMed
    Score: 0.209
  8. TET2-mutant clonal hematopoiesis and risk of gout. Blood. 2022 Sep 08; 140(10):1094-1103.
    View in: PubMed
    Score: 0.062
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.